An Observational Study of Trifluridine/Tipiracil-Containing Regimen Versus Regorafenib-Containing Regimen in Patients With Metastatic Colorectal Cancer

BACKGROUND: There are no randomized control trials comparing the efficacy of trifluridine/tipiracil and regorafenib in patients with metastatic colorectal cancer (mCRC). Herein, we conducted an observational study to compare the oncologic outcomes of trifluridine/tipiracil-containing regimen (TAS-10...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsieh, Meng-Che, Rau, Kun-Ming, Lin, Shung-Eing, Liu, Kuang-Wen, Chiu, Chong-Chi, Chen, Chih-I, Song, Ling-Chiao, Chen, Hsin-Pao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160360/
https://www.ncbi.nlm.nih.gov/pubmed/35664763
http://dx.doi.org/10.3389/fonc.2022.867546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160360/
https://www.ncbi.nlm.nih.gov/pubmed/35664763
http://dx.doi.org/10.3389/fonc.2022.867546

Ejemplares similares